CellsBin Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.3M

  • Investors
  • 7

CellsBin General Information

Description

Developer of a rare-cell analysis platform designed to support precision medicine, diagnostics, and cell therapy monitoring. The company offers rare-cell detection, single-cell profiling, molecular diagnostics, AI-driven biological intelligence, therapeutic cell monitoring, and precision medicine platforms, enabling researchers, clinicians, and biopharmaceutical companies to detect, quantify, and analyze rare cells for disease monitoring, treatment response assessment, and clinical decision-making.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 College Street
  • Branford, CT 06510
  • United States
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 101 College Street
  • Branford, CT 06510
  • United States

CellsBin Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellsBin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 22-Sep-2026 $7.3M Completed Generating Revenue
3. Accelerator/Incubator 16-Oct-2025 Completed Generating Revenue
2. Accelerator/Incubator 24-Oct-2023 Completed Startup
1. Accelerator/Incubator 10-May-2023 Completed Startup
To view CellsBin’s complete valuation and funding history, request access »

CellsBin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Series A 82,731,000 $0.000010 8% $0.07 $0.07 1x $0.07 32.55%
To view CellsBin’s complete cap table history, request access »

CellsBin Patents

CellsBin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025155756-A1 Devices for biological analysis Inactive 17-Jan-2024
US-12188866-B2 Devices for biological analysis Active 18-Jul-2022
US-20240210317-A1 Devices for biological analysis Active 18-Jul-2022
US-20250237602-A1 Devices for biological analysis Pending 18-Jul-2022
WO-2024019988-A1 Devices for biological analysis Inactive 18-Jul-2022 G01N21/4788
To view CellsBin’s complete patent history, request access »

CellsBin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellsBin Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
108 BioCapital Other Private Equity Minority
Connecticut Innovations Venture Capital Minority
Hatcher+ Venture Capital Minority
Plug and Play Accelerator/Incubator Minority
Endless Frontier Labs Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

CellsBin FAQs

  • When was CellsBin founded?

    CellsBin was founded in 2022.

  • Where is CellsBin headquartered?

    CellsBin is headquartered in Branford, CT.

  • What is the size of CellsBin?

    CellsBin has 10 total employees.

  • What industry is CellsBin in?

    CellsBin’s primary industry is Discovery Tools (Healthcare).

  • Is CellsBin a private or public company?

    CellsBin is a Private company.

  • What is the current valuation of CellsBin?

    The current valuation of CellsBin is .

  • What is CellsBin’s current revenue?

    The current revenue for CellsBin is .

  • How much funding has CellsBin raised over time?

    CellsBin has raised $7.3M.

  • Who are CellsBin’s investors?

    108 BioCapital, Connecticut Innovations, Hatcher+, Plug and Play, and Endless Frontier Labs are 5 of 7 investors who have invested in CellsBin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process